Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study).
Alfonso F, Cuesta J, Ojeda S, Camacho-Freire S, García Del Blanco B, Vaquerizo B, Zueco J, Trillo R, Mauri J, Velázquez M, Córdoba-Soriano JG, Serra A, Navarro F, Pan M, Díaz J, Otaegui I, Salvatella N, De la TorreHernandez JM, Val DD, Bastante T, Rivero F; Under the auspices of the Association of Interventional Cardiology of the Spanish Society of Cardiology. Alfonso F, et al. Among authors: mauri j. Am J Cardiol. 2022 Jan 1;162:31-40. doi: 10.1016/j.amjcard.2021.09.027. Am J Cardiol. 2022. PMID: 34903344 Clinical Trial.
Long-Term Intracoronary Structural and Vasomotor Assessment of the ABSORB Bioresorbable Vascular Scaffold.
Altisent OA, Goncalves-Ramírez LR, Fernández L, Viladés D, Gutiérrez E, Mitomo S, Latib A, Córdoba-Soriano JG, Adeliño R, Amat-Santos I, Muñoz JF, Elízaga J, Bezzera H, Pereira GTR, de Prado AP, Carrillo X, Fernández-Nofrerias E, Vilalta V, Rodríguez-Leor O, Llibre C, Fadeuilhe E, Trujillo A, Mauri J, de la Torre Hernández JM, Bayes-Genís A, Puri R. Altisent OA, et al. Among authors: mauri j. Am J Cardiol. 2022 Apr 1;168:55-63. doi: 10.1016/j.amjcard.2021.12.037. Epub 2022 Jan 17. Am J Cardiol. 2022. PMID: 35058053
Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year.
Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Masotti-Centol M, Carrillo X, Mauri J, Batalla N, Larrousse E, Martín E, Serra A, Rumoroso JR, Ruiz-Salmerón R, de la Torre JM, Cequier A, Gómez-Hospital JA, Alfonso F, Martín-Yuste V, Sabatè M, García-Dorado D. Ferreira-González I, et al. Among authors: mauri j. J Am Coll Cardiol. 2012 Oct 9;60(15):1333-9. doi: 10.1016/j.jacc.2012.04.057. Epub 2012 Sep 19. J Am Coll Cardiol. 2012. PMID: 22999716 Free article.
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial.
Colombo A, Chieffo A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N, Oteo Dominguez JF, Steffanon L, Tarantini G, Presbitero P, Menozzi A, Pucci E, Mauri J, Cesana BM, Giustino G, Sardella G. Colombo A, et al. Among authors: mauri j. J Am Coll Cardiol. 2014 Nov 18-25;64(20):2086-97. doi: 10.1016/j.jacc.2014.09.008. Epub 2014 Sep 15. J Am Coll Cardiol. 2014. PMID: 25236346 Free article. Clinical Trial.
Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
de la Torre-Hernández JM, Alfonso F, Hernández F, Elizaga J, Sanmartin M, Pinar E, Lozano I, Vazquez JM, Botas J, Perez de Prado A, Hernández JM, Sanchis J, Nodar JM, Gomez-Jaume A, Larman M, Diarte JA, Rodríguez-Collado J, Rumoroso JR, Lopez-Minguez JR, Mauri J; ESTROFA Study Group. de la Torre-Hernández JM, et al. Among authors: mauri j. J Am Coll Cardiol. 2008 Mar 11;51(10):986-90. doi: 10.1016/j.jacc.2007.10.057. J Am Coll Cardiol. 2008. PMID: 18325436 Free article.
Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2).
de la Torre Hernández JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, Pérez de Prado A, Rivero F, Sanchis J, Larman M, Diaz JF, Elizaga J, Moreiras JM, Gomez Jaume A, Hernández JM, Mauri J, Recalde AS, Bullones JA, Rumoroso JR, Del Blanco BG, Baz JA, Bosa F, Botas J, Hernández F; ESTROFA-2 Study Group. de la Torre Hernández JM, et al. Among authors: mauri j. JACC Cardiovasc Interv. 2010 Sep;3(9):911-9. doi: 10.1016/j.jcin.2010.06.010. JACC Cardiovasc Interv. 2010. PMID: 20850089 Free article.
Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: Does time matter?
Giralt T, Ribas N, Freixa X, Sabaté M, Caldentey G, Tizón-Marcos H, Carrillo X, García-Picart J, Lidón RM, Cárdenas M, Pérez-Fernández S, Mauri J, Vaquerizo B. Giralt T, et al. Among authors: mauri j. Int J Cardiol. 2021 Feb 15;325:9-15. doi: 10.1016/j.ijcard.2020.09.058. Epub 2020 Sep 28. Int J Cardiol. 2021. PMID: 32991944
200 results